Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Ранг среди акций #16436
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Цена акции
$4.64
Последняя синхронизация: 2022-09-12
Рыночная капитализация
$293.43M
Изменение (1 день)
0.87%
Изменение (1 год)
0.00%
Страна
US
Торговля Adagio Therapeutics, Inc. (ADGI)

Категория

История цены акций Adagio Therapeutics, Inc. (ADGI)
Наивысшая цена закрытия: $4.63 2022-09-01

Наименьшая цена закрытия: $27.68 2021-08-01
История цены акций Adagio Therapeutics, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2022 -78.16%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.14 -10.08%
AU
$748.60 6.90%
CH